40 results
6-K
EX-99.1
IFRX
InflaRx N.V.
28 Jun 24
Leerink Partners LLC
4:55pm
action, order or decree of any court or arbitrator or governmental or regulatory authority.
(f) Distribution of Offering Materials. The Company has … suspended on, and the Ordinary Shares shall not have been delisted from, Nasdaq.
(l) Other Materials. On each date on which the Company is required
6-K
IFRX
InflaRx N.V.
4 Apr 24
Current report (foreign)
4:01pm
meeting of shareholders to be held on April 25, 2024 and made available to its shareholders certain other materials in connection with such meeting … . Such materials are attached as exhibits to this Form 6-K and are incorporated by reference herein.
EXHIBIT INDEX
Exhibit
Description of Exhibit
99.1
6-K
EX-99.1
IFRX
InflaRx N.V.
21 Mar 24
InflaRx Reports Full Year 2023 Results and Announces INF904 Development Plans
7:05am
) revenues in the United States and to write-downs of inventory.
Costs of sales for products sold in these periods do not include costs of materials … , as the associated costs of these materials were incurred in prior periods, before the FDA granted an EUA for GOHIBIC (vilobelimab) in April 2023
6-K
EX-99.1
IFRX
InflaRx N.V.
1 Nov 23
Current report (foreign)
8:04am
2, inventories are stated at the lower amount of their cost or at their net realizable value. Cost comprises direct materials and, where applicable … . Costs of sales for products sold in these periods do not include costs of materials, as the associated costs of these materials were incurred in prior
6-K
EX-99.2
61xiub
1 Nov 23
Current report (foreign)
8:04am
6-K
EX-99.3
rz6zsh78
1 Nov 23
Current report (foreign)
8:04am
6-K
EX-99.2
d8oug4pco0di so
10 Aug 23
Report of Foreign Private Issuer
8:00am
6-K
EX-99.1
otjj9kwt4as fp
10 Aug 23
Report of Foreign Private Issuer
8:00am
F-3
EX-4.3
g7bislg
30 Jun 23
Shelf registration (foreign)
4:06pm
6-K
EX-99.2
jrgncjus
11 May 23
Current report (foreign)
8:00am
6-K
EX-1.1
pzt6o 7gkl2x6t
13 Apr 23
Current report (foreign)
4:01pm
424B5
c2dgi6eggqm6odfl u5q
13 Apr 23
Prospectus supplement for primary offering
8:48am
424B5
ftdcn7rh99fb5 wcdn7
11 Apr 23
Prospectus supplement for primary offering
4:11pm
6-K
uo3v iw0c3
5 Apr 23
Current report (foreign)
4:01pm
6-K
EX-10.1
pco3b1 229srbl
21 Dec 22
Current report (foreign)
7:45am
6-K
EX-10.2
ljhdx9szbv87
21 Dec 22
Current report (foreign)
7:45am
6-K
dukwt8gtml
7 Apr 22
Current report (foreign)
4:01pm
6-K
EX-99.1
hn6j76
24 Mar 22
InflaRx Reports Full Year 2021 Financial and Operating Results
8:40am